GCM
TMO icon

Gladius Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Gladius Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,000
Closed -$4.42M – 351
2024
Q2 		$4.42M Buy
8,000
+4,900
+158% +$2.81M 0.54% 19
2024
Q1 		$1.8M Sell
3,100
-2,300
-43% -$1.29M 0.59% 31
2023
Q4 		$2.87M Sell
5,400
-5,500
-50% -$2.66M 0.45% 50
2023
Q3 		$5.52M Buy
10,900
+5,500
+102% +$2.93M 0.23% 80
2023
Q2 		$2.82M Sell
5,400
-8,100
-60% -$4.37M 0.14% 68
2023
Q1 		$7.78M Buy
13,500
+11,400
+543% +$6.43M 0.45% 45
2022
Q4 		$1.16M Sell
2,100
-3,500
-63% -$1.85M 0.08% 68
2022
Q3 		$2.84M Buy
+5,600
New +$3.13M 0.13% 72
2022
Q2 		– Sell
-1,100
Closed -$650K – 425
2022
Q1 		$650K Sell
1,100
-4,400
-80% -$2.53M 0.05% 88
2021
Q4 		$3.67M Buy
5,500
+2,200
+67% +$1.37M 0.29% 47
2021
Q3 		$1.89M Hold
3,300
– – 0.13% 36
2021
Q2 		$1.67M Sell
3,300
-25,000
-88% -$11.8M 0.16% 47
2021
Q1 		$12.9M Sell
28,300
-5,300
-16% -$2.53M 0.49% 57
2020
Q4 		$15.7M Buy
33,600
+23,900
+246% +$11.2M 0.77% 45
2020
Q3 		$4.28M Buy
+9,700
New +$4.01M 0.43% 35
2020
Q1 		– Sell
-3,200
Closed -$1.04M – 178
2019
Q4 		$1.04M Hold
3,200
– – 0.07% 129
2019
Q3 		$933K Hold
3,200
– – 0.04% 161
2019
Q2 		$959K Buy
+3,200
New +$881K 0.06% 97

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gladius Capital Management's TMO Position: Q3 2024 in Review

Gladius Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 3,710 shares — an estimated $2.05M sold.

Gladius Capital Management first reported a position in TMO in Q3 2019 and held it in 14 quarters. The position peaked at $2.85M in Q3 2023. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Gladius Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,710 Thermo Fisher Scientific shares in Q3 2024, an estimated $2.05M.
  • Gladius Capital Management first reported a position in Thermo Fisher Scientific in Q3 2019 and held it in 14 quarters.
  • Gladius Capital Management's Thermo Fisher Scientific position peaked at $2.85M in Q3 2023.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Gladius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.